logo
Should we treat HCV carriers with normal ALT levels? The ‘5Ws’ dilemma
Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C
Lymphotropic hepatitis C virus has an interferon-resistant phenotype
Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study *
Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis
Reversal of nonstructural protein 3-specific CD4+ T cell dysfunction in patients with persistent hepatitis C virus infection
Inhibition effect produced by dominant negative mutant fusion protein PreS2-TLM-ScFv-HBcDN on HBV replication in vitro